What is .decimal?
.decimal operates as a specialized manufacturer of custom, patient-specific radiation therapy devices, catering to Proton, Electron, and Photon treatments. The company's core competency lies in its on-demand design and delivery services, which have supported over 150,000 cancer patients across 949 clinics in the United States. With a production history of 530,639 devices, .decimal is dedicated to providing tailored solutions that enhance the efficacy and precision of cancer treatment protocols. Their services extend to contract manufacturing and providing essential material safety data sheets, positioning them as a critical partner in the oncology supply chain.
How much funding has .decimal raised?
.decimal has raised a total of $975K across 2 funding rounds:
Debt
$350K
Debt
$625K
Debt (2020): $350K with participation from PPP
Debt (2021): $625K led by PPP
Key Investors in .decimal
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for .decimal?
The recent major strategic investment signals a new phase of growth and innovation for .decimal. This capital infusion is anticipated to accelerate the company's research and development efforts, potentially expanding its product portfolio and enhancing its manufacturing capacity. Strategic partnerships and further market penetration within the United States and potentially internationally are likely objectives. The company may also focus on optimizing its supply chain and operational efficiencies to meet the increasing demand for personalized radiation therapy devices, solidifying its role as a leader in this specialized medical technology niche.
See full .decimal company page
